AnaptysBio(MX:ANAB)
MX$920.00+252.00 (+37.72%)
MX:ANAB
AnaptysBio earnings date
MX$920.00
At close:+252.00 (+37.72%)
AnaptysBio (ANAB) Q1 2020 Earnings Report
0 Followers
MX:ANAB Q1 2020 EPS Results
- Actual EPS
- -MXN 5.58
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -MXN 15.24
MX:ANAB Q1 2020 Revenue Results
- Actual Revenue
- MXN 278.84M
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q1 2020
- Date
- 05/06/2020
- Time
- TBA
- Conference Call
- Wednesday, May 6, 2020
MX:ANAB Upcoming Earnings
AnaptysBio's next earnings date is estimated for March 9, 2027, based on past reporting schedules.
Q1 2020 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q1 2020 Earnings Slide Deck
No slide deck is available for this earnings event.
Q1 2020 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:ANAB Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 09, 2027 | 2026 (Q4) | 94.9994.99 | 29.43 | 222.80% (+65.56) | ― |
| Nov 12, 2026 | 2026 (Q3) | ―-34.20 | 9.69 | -453.17% (-43.89) | |
| Sep 21, 2026 | 2026 (Q2) | -16.60-16.60 | -16.6 | 0.00% (+0.00) | |
| May 12, 2026 | 2026 (Q1) | 6.45-15.86 | -23.85 | 33.52% (+7.99) | |
| Mar 03, 2026 | 2025 (Q4) | -16.6029.43 | -8.92 | 429.79% (+38.35) | |
| Nov 04, 2025 | 2025 (Q3) | -15.869.69 | -14.13 | 168.55% (+23.81) | |
| Aug 06, 2025 | 2025 (Q2) | -8.92-24.93 | -21.19 | -17.63% (-3.74) | |
| May 05, 2025 | 2025 (Q1) | -14.13-23.85 | -20.32 | -17.38% (-3.53) | |
| Feb 27, 2025 | 2024 (Q4) | -20.06-8.92 | -19.7 | 54.72% (+10.78) | |
| Nov 05, 2024 | 2024 (Q3) | -20.41-14.13 | -17.47 | 19.15% (+3.35) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
